SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $9,072,000 | +7.6% | 200,000 | -20.0% | 0.16% | +6.1% |
Q2 2017 | $8,428,000 | -43.1% | 250,000 | -50.0% | 0.15% | -55.2% |
Q1 2017 | $14,800,000 | -32.6% | 500,000 | -37.5% | 0.33% | -32.6% |
Q4 2016 | $21,944,000 | +19.1% | 800,000 | +166.7% | 0.49% | +33.4% |
Q3 2016 | $18,423,000 | +866.1% | 300,000 | +200.0% | 0.36% | +835.9% |
Q2 2016 | $1,907,000 | -51.2% | 100,000 | -50.0% | 0.04% | -48.7% |
Q1 2016 | $3,904,000 | +1.2% | 200,000 | +100.0% | 0.08% | +5.6% |
Q4 2015 | $3,858,000 | – | 100,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |